CLINICAL SIGNIFICANCE OF WHITE CINQUEFOIL (POTENTILLA ALBA L.) IN THE CORRECTION OF THYROID PATHOLOGIES

Main Article Content

Komiljonova Oygul Olimjonovna

Abstract

Thyroid gland disorders occupy a leading position in the overall structure of endocrine diseases worldwide. Iodine deficiency is recognized as one of the principal etiological factors contributing to the development of thyroid pathologies[2]. Currently applied therapeutic approaches do not always ensure stable and pathogenetically justified outcomes. In this context, increasing scientific attention is being directed toward medicinal plants rich in biologically active compounds capable of regulating thyroid function. White cinquefoil (Potentilla alba) has emerged as a promising natural source of thyrotropic substances. The present article analyzes literature data on iodine deficiency disorders, pathogenetic mechanisms of thyroid diseases, limitations of conventional treatment methods, and the clinical relevance of Potentilla alba as a safe and effective phytotherapeutic agent in thyroid pathology correction[1].

Downloads

Download data is not yet available.

Article Details

Section

Articles

How to Cite

CLINICAL SIGNIFICANCE OF WHITE CINQUEFOIL (POTENTILLA ALBA L.) IN THE CORRECTION OF THYROID PATHOLOGIES. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(01), 1028-1031. https://doi.org/10.55640/ (Original work published 2026)

References

1.Balabolkin MI. Resolved and unresolved issues of endemic goiter and iodine deficiency conditions. Problems of Endocrinology (Endokrinologiya muammolari). 2015;51(4):31–33.

2.Gerasimov GA. Chernobyl: 20 Years Later. The Role of Iodine Deficiency in the Development of Thyroid Diseases. Moscow; 2016. 115 p.

3.Gerasimov GA, Fadeev VV, Sviridenko NYu. Iodine Deficiency-Related Diseases in Russia. Moscow; 2012. 96 p.

4.Gritsenko LM. Phytochemical composition of white cinquefoil (Potentilla alba). Pharmaceutical Journal (Farmatsevtika jurnali). 1977;(1):88–91.

5.Dedov II. Diagnosis and Management of Nodular Goiter: Methodological Guidelines. Moscow; 2011. 69 p.

6.Dedov II, Gerasimov GA, Sviridenko NYu. Iodine Deficiency Disorders in the Russian Federation: Methodological Guidelines. Moscow; 1999. 130 p.

7.Dedov II, Melnichenko GA, Peterkova VA, et al. Results of epidemiological studies on iodine deficiency disorders within the “Thyro-Mobile” project. Problems of Endocrinology (Endokrinologiya muammolari). 2015;51(5):32.

8.Iodine Deficiency: A Threat to the Health and Development of Russian Children. Solutions to the Problem: National Report. Moscow; 2016.

9.Kiyaev AV, Sumin MN, Saveliev LI. Choice of treatment strategy for Graves’ disease in children. Clinical Endocrinology (Klinik endokrinologiya). 2018;54(1):29.

10.Korsun VF, et al. Phytotherapy in Endocrine Diseases: A Guide for Residents and Physicians. Moscow: RUDN University; 2014. 45 p.

11.Maklakova LP, Appengals LV, Zorina VN, et al. Iron metabolism in diffuse goiter among the indigenous population of the Mountain Altai region. Problems of Endocrinology (Endokrinologiya muammolari). 2018;54(1):36.

12.Sviridenko NYu. Functional autonomy in diffuse goiter. Problems of Endocrinology (Endokrinologiya muammolari). 2015;51(1):40–42.

13.Smyk GK. White cinquefoil (Potentilla alba) as an effective agent in the treatment of thyroid diseases. Pharmaceutical Journal (Farmatsevtika jurnali). 1975;(2):58–62.

14.Suplotova LA, Kurovina EF, Sharukho GV, et al. Monitoring system of iodine deficiency conditions in Western Siberia. Problems of Endocrinology (Endokrinologiya muammolari). 2018;54(3):14–17.

15.Fadeev VV. Iodine Deficiency and Autoimmune Thyroid Diseases in a Mild Iodine-Deficient Area [dissertation abstract]. Moscow; 2014. 25 p.

Similar Articles

You may also start an advanced similarity search for this article.